CVE-2022-26088

Public Exploit

Description

An issue was discovered in BMC Remedy before 22.1. Email-based Incident Forwarding allows remote authenticated users to inject HTML (such as an SSRF payload) into the Activity Log by placing it in the To: field. This affects rendering that occurs upon a click in the "number of recipients" field. NOTE: the vendor's position is that "no real impact is demonstrated."

Category

5.4
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.18%
Third-Party Advisory packetstormsecurity.com Third-Party Advisory seclists.org Third-Party Advisory sec-consult.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://sec-consult.com/vulnerability-lab/advisory/html-injection-in-bmc-remedy-itsm-suite/ third party advisory exploit
http://seclists.org/fulldisclosure/2022/Nov/10 mailing list third party advisory exploit
http://packetstormsecurity.com/files/169863/BMC-Remedy-ITSM-Suite-9.1.10-20.02-HTML-Injection.html third party advisory exploit

Frequently Asked Questions

What is the severity of CVE-2022-26088?
CVE-2022-26088 has been scored as a medium severity vulnerability.
How to fix CVE-2022-26088?
To fix CVE-2022-26088, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-26088 being actively exploited in the wild?
It is possible that CVE-2022-26088 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.